Relationship between previous treatments and onset of symptoms in patients with Whipple's disease

Internal and Emergency Medicine

Volumn 9, Issue 2, 2014, Pages 161-164

  Trotta, Lucia ^a   Biagi, Federico ^a   Di Stefano, Michele ^a   Corazza, Gino Roberto ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Immunosuppressive therapy; Small bowel; Tropheryma whipplei; Whipple's disease

Indexed keywords

ADULT; AGED; COMPLICATION; FEMALE; HUMAN; MALE; MIDDLE AGED; WHIPPLE DISEASE;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; WHIPPLE DISEASE;

EID: 84894448599     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-012-0799-4     Document Type: Article

References (21)

1. Fennolar F, Puechal X, Raoult D (2007) Whipple's disease. N Engl J Med 356: 55-66.
2. Schneider T, Moos V, Loddenkemper C, Marth T, Fenollar F, Raoult D (2008) Whipple's disease: new aspects of pathogenesis and treatment. Lancet Infect Dis 8: 179-190.
3. Relman DA, Schmidt TM, MacDermott RP, Falkow S (1992) Identification of the uncultured bacillus of Whipple's disease. N Engl J Med 327: 293-301.
4. Raoult D, Birg ML, La Scola B, Fournier PE, Enea M, Lepidi H, Roux V, Piette JC, Vandenesch F, Vital-Durand D, Marrie TJ (2000) Cultivation of the bacillus of Whipple's disease. N Engl J Med 342: 620-625.
5. Schöniger-Hekele M, Petermann D, Weber B, Müller C (2007) Tropheryma whipplei in the environment: survey of sewage plant influxes and sewage plant workers. Appl Environ Microbiol 73: 2033-2035.
6. Lagier JC, Fenollar F, Lepidi H, Raoult D (2011) Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple's disease. J Antimicrob Chemother 66: 1188-1189.
7. Li W, Fennolar F, Rolain J-M, Fournier P-E, Feurle GE, Müller C, Moos V, Marth T, Altwegg M, Calligaris-Maibach RC, Schneider T, Biagi F, La Scola B, Raoult D (2008) Genotyping reveals a wide heterogeneity of Tropheryma whipplei. Microbiology 154: 521-527.
8. Martinetti M, Biagi F, Badulli C, Feurle GE, Müller C, Moos V, Schneider T, Marth T, Marchese A, Trotta L, Sachetto S, Pasi A, De Silvestri A, Salvaneschi L, Corazza GR (2009) The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple's disease. Gastroenterology 136: 2289-2294.
9. Marth T, Kleen N, Stallmach A, Ring S, Aziz S, Schmidt C, Strober W, Zeitz M, Schneider T (2002) Dysregulated peripheral and mucosal Th1/Th2 response in Whipple's disease. Gastroenterology 123: 1468-1477.
10. Fennolar F, Raoult D (2001) Whipple's disease. Clin Diagn Lab Immunol 8: 1-8.
11. Dutly F, Altwegg M (2001) Whipple's disease and Tropheryma whippelii". Clin Microbiol Rev 14: 561-583.
12. Di Stefano M, Jorizzo RA, Brusco G, Cecchetti L, Sciarra G, Loperfido S, Brandi G, Gasbarrini G, Corazza GR (1998) Bone mass and metabolism in Whipple's disease: the role of hypogonadism. Scand J Gastroenterol 33: 1180-1185.
13. Raoult D, La Scola B, Lecocq P, Lepidi H, Fournier PE (2001) Culture and immunological detection of Tropheryma whippelii from the duodenum of a patient with Whipple disease. JAMA 285: 1039-1043.
14. Feurle GE, Junga NS, Marth T (2010) Efficacy of ceftriaxone or meropenem as initial therapies in Whipple's disease. Gastroenterology 138: 478-486.
15. Lagier JC, Fenollar F, Lepidi H, Raoult D (2011) Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple's disease. J Antimicrob Chemother 66: 1188-1189.
16. Mahnel R, Kalt A, Ring S, Stallmach A, Strober W, Marth T (2005) Immunosuppressive therapy in Whipple's disease patients is associated with the appearance of gastrointestinal manifestations. Am J Gastroenterol 100: 1167-1173.
17. Feurle GE, Moos V, Schinnerling K, Geelhaar A, Allers K, Biagi F, Bläker H, Moter A, Loddenkemper C, Jansen A, Schneider T (2010) The immune reconstitution inflammatory syndrome in Whipple disease. A cohort study. Ann Intern Med 153: 710-717.
18. Lamparter S, Dittrich C, Koehler HH (2008) Exacerbation of WD by immunosuppressants. J Clin Gastroenterol 42: 760-761.
19. Kneitz C, Suerbaum S, Beer M, Müller J, Jahns R, Tony HP (2005) Exacerbation of Whipple's disease associated with infliximab treatment. Scand J Rheumatol 34: 148-151.
20. Hoppè E, Masson C, Audran M, Drillon M, Andreu M, Saraux A, Berthelot JM, Maugars Y, Hmamouchi I, Morel J (2010) Whipple's disease diagnosed during biological treatment for joint disease. Joint Bone Spine 77: 335-339.
21. Corazza GR, Brusco G, Andreani ML, Biagi F, Di Stefano M, Gasbarrini G (1996) Previous misdiagnosis and diagnostic delay in adult celiac sprue. J Clin Gastroenterol 22: 324-325.